Cargando…
Formononetin Treatment in Type 2 Diabetic Rats Reduces Insulin Resistance and Hyperglycemia
Type 2 diabetic mellitus is a multifactorial metabolic disorder affecting huge population around the world. This indicates that there is an urgent unmet need of cost effective, new treatment strategies for type 2 diabetes mellitus with no or less side effects. Phenolic compounds including isoflavone...
Autores principales: | Oza, Manisha J., Kulkarni, Yogesh A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058024/ https://www.ncbi.nlm.nih.gov/pubmed/30072892 http://dx.doi.org/10.3389/fphar.2018.00739 |
Ejemplares similares
-
Treatment with Terminalia chebula Extract Reduces Insulin Resistance, Hyperglycemia and Improves SIRT1 Expression in Type 2 Diabetic Rats
por: Agrawal, Ojaskumar D., et al.
Publicado: (2023) -
A flavonoid-rich fraction of Euphorbia peplus attenuates hyperglycemia, insulin resistance, and oxidative stress in a type 2 diabetes rat model
por: Alruhaimi, Reem S., et al.
Publicado: (2023) -
Formononetin: A Review of Its Anticancer Potentials and Mechanisms
por: Tay, Kai-Ching, et al.
Publicado: (2019) -
Focusing on Formononetin: Recent Perspectives for its Neuroprotective Potentials
por: Tian, Jiao, et al.
Publicado: (2022) -
Formononetin Activates the Nrf2/ARE Signaling Pathway Via Sirt1 to Improve Diabetic Renal Fibrosis
por: Zhuang, Kai, et al.
Publicado: (2021)